Market Report -- In Play (WIRES)
MSN Money - USA
Acorda Therapeutics (ACOR) announces that Andrew Goodman will present data from Acorda's MS-F203 Phase 3 clinical trial of Fampridine-SR in multiple ...
See all stories on this topic